LMF Acquisition Opportunities, Inc. (LMAO)

NASDAQ: LMAO · IEX Real-Time Price · USD
10.16
0.00 (0.00%)
Jun 24, 2022 12:00 AM EDT - Market closed
0.00%
Market Cap 132.50M
Revenue (ttm) n/a
Net Income (ttm) 1.75M
Shares Out 13.04M
EPS (ttm) 0.13
PE Ratio 75.82
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Open 10.16
Previous Close 10.16
Day's Range 10.16 - 10.16
52-Week Range 9.81 - 12.16
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About LMAO

LMF Acquisition Opportunities, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Tampa, Florida. [Read more...]

Industry Blank Check / SPAC
IPO Date Jan 26, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol LMAO
Full Company Profile

News

SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality...

Results published in the Society of Critical Care Management's journal, Critical Care Explorations Results published in the Society of Critical Care Management's journal, Critical Care Explorations

Skyway Capital Markets Advises SPAC on $85 Million Medical Technology Merger

TAMPA, Fla.--(BUSINESS WIRE)--Skyway Capital Markets, LLC (“Skyway”) is pleased to announce the merger of SeaStar Medical, Inc. (“SeaStar Medical”), a medical technology company developing extracorporea...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CDK, TGNA, LMAO, MTOR, TEN

NEW YORK , April 25, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...

Other symbols: CDKMTORTENTGNA

SeaStar Medical is getting NASDAQ listing via a merger with LMAO

SeaStar Medical Inc, a medical tech corporation focusing on the development of extracorporeal therapy treatments to reduce the symptoms of vital organ inflammation, is merging with LMF Acquisition Oppor...

SeaStar Medical to Become Publicly Listed on Nasdaq via Business Combination with LMF Acquisition Opportunities, Inc.

DENVER and TAMPA, Fla., April 22, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, Inc. (“SeaStar Medical”), a medical technology company developing extracorporeal therapies to reduce the consequences of exces...

LMF Acquisition Opportunities, Inc. Announces Separate Trading of its Class A Common Stock and Warrants, Commencing M...

TAMPA, FL / ACCESSWIRE / March 17, 2021 / LMF Acquisition Opportunities, Inc. (NASDAQ:LMAOU) (the "Company") announced that, commencing March 18, 2021, holders of the units sold in the Company's initial...